Scope International AG is pleased to announce the appointment of Björn Boße as new head of biostatistics. Together with Dr. Klaus Junge as Senior Biostatisticial Advisor Scope International offers an exceptional expertise in biostatistics. Björn and Klaus have both more than 20 years of experience in the pharmaceutical industry as e.g. Director Biostatistics and Executive Director European Biostatistics, respectively. Due to their outstanding expert knowledge in many indications, they will contribute to expanding several business areas of SCOPE.
NewsSpotlight on our Biostatistic experts and strategic consulting team
Scope International AG is pleased to announce the appointment of Adam Braithwaite as the key contact for Business Development in the U.S. Adam will join the SCOPE BD team as part of its North American subsidiary, Scope International USA, based in Pittsburgh, PA. In his new position, he will support our clients for their ongoing needs and will support the development of future products together with our customers.
NewsAdam Braithwaite appointed to the Business Development Team for the U.S.
Scope International AG has announced the appointment of Andrew Bradshaw as the new UK Managing Director for its subsidiary, based in Manchester, UK. Guiding a highly motivated and qualified team, Andrew will be responsible for the strategic development of Scope International (UK) Ltd.
Scope International AG is pleased to announce the appointment of Amy O’Sullivan as the new Managing Director of its North American subsidiary, based in Pittsburgh, Pennsylvania. Guiding SCOPE’s business in our fastest growing market, Amy will take over an essential part of our strategic development and leading a growing team.
NewsNew Managing Director for North American Operations
Our clinical trial management system InSIGHT now has an electronic signature feature which allows you to sign and authorize study documents more quickly. This new, easy to use feature allows for controlled, accelerated collection of multiple signatures on one document.
According to Art. 244 quarter B of the French Fiscal code, companies may be granted a research tax credit based on their research and technological development («R&D») expenditures. The corresponding activities may be entrusted to organizations or experts approved beforehand by the ministry for research.
NewsRenewal of French Research Tax Credit Accreditation (CIR)
Scope International in Spain is now partner of CataloniaBio, which is the association of companies in the health and life sciences area in Catalonia. The mission of this cluster is to build an innovative cluster, as well as helping to define the framework for sector-wide actions and industrial policies established at a national and European level.
SCOPE International USA is hosting a special Ribbon Cutting Ceremony with Pittsburgh’s Mayor William Peduto, The Pennsylvania Biotechnology Association CEO/President Chris Molineaux, Pittsburgh’s German American Chamber of Commerce Chairman/President Paul Overby, and Vice President, Global Business Development at Pittsburgh Regional Alliance (PRA) Suzi Pegg, in celebration of it’s rapid growth of business and move into new offices.
In a further development of Scope’s International’s commitment to the UK Drug and Device development industry, Scope’s UK offices and capabilities are featured in an article in ‘Spring ON Highlights’ from One Nucleus (ON).
NewsPress: Article in ‘Spring ON Highlights’ about our UK office